Re: role of controlled drug delivery for periodontitis (position paper). The American Academy of Periodontology (2000;71:12-40).
Finkelman
R D
RD
D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D002710:Chlorhexidine / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003692:Delayed-Action Preparations; D012534:Dental Scaling; D016503:Drug Delivery Systems; D006801:Humans; D015337:Multicenter Studies as Topic; D010514:Periodontal Pocket / Q000188:drug therapy / Q000628:therapy; D010518:Periodontitis / Q000188:drug therapy* / Q000628:therapy; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D016745:Root Planing; D016896:Treatment Outcome; D003245:Consensus Statements as Topic
D000890:Anti-Infective Agents; D003692:Delayed-Action Preparations; D002710:Chlorhexidine